Waldencast Plc (WALD)

$1.89 0.00 (N/A)
Market Cap 230.72M
Revenue (ttm) 273.87M
Net Income (ttm) -42.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -15.50%
Debt to Equity Ratio 0.23
Volume 241,600
Avg Vol 94,210
Day's Range N/A - N/A
Shares Out 122.08M
Stochastic %K 89%
Beta -0.40
Analysts Sell
Price Target $3.50

Company Profile

Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; cosmetics; and other beauty products. In addition, the company provides foundation, concealer, primer,...

Industry: Household & Personal Products
Sector: Consumer Defensive
Address:
10 Bank Street, Suite 560, White Plains, United States
AlertsAndNews
AlertsAndNews Nov. 16 at 11:25 PM
$WALD Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting "Interim data from the ongoing study of Obagi Nu-Cil® BioStim™ Scalp Serum highlights improvements in scalp health and hair appearance at three months."
0 · Reply
premarketmaker
premarketmaker Nov. 14 at 10:51 PM
$WALD
0 · Reply
DARKP00L
DARKP00L Nov. 14 at 10:39 PM
$WALD 17:09 on Nov. 14 2025 Waldencast Plc Sells Its Rights To The "Obagi" Trademark In Japan To Rohto Pharmaceutical For $82.5M #tradeideas
0 · Reply
premarketmaker
premarketmaker Nov. 14 at 10:38 PM
$WALD big sale just announced!
0 · Reply
premarketmaker
premarketmaker Nov. 14 at 10:18 PM
$WALD $2.62 upper targets product scope
0 · Reply
MahiMe
MahiMe Nov. 14 at 10:10 PM
$WALD Waldencast (NASDAQ: WALD) announced a $82.5 million sale of its rights to the “Obagi” trademark in Japan to Rohto Pharmaceutical and a new $225 million secured, three-year first-lien term loan facility with funds managed by Lumina Capital, with proceeds expected by Nov 17, 2025.
0 · Reply
MahiMe
MahiMe Nov. 14 at 10:08 PM
$WALD $WALD Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities https://www.stocktitan.net/news/WALD/waldencast-plc-strengthens-balance-sheet-position-with-the-twbx7vmb0t8u.html
0 · Reply
Zero11
Zero11 Nov. 11 at 10:02 PM
$WALD arent the esrnings supposed to come out today
0 · Reply
SmartMoneySarge
SmartMoneySarge Oct. 17 at 4:17 AM
$UNTY $WALD
0 · Reply
Stocktwits
Stocktwits Oct. 16 at 8:21 PM
🚨 What's Happening Tomorrow ▪ Hourly Earnings YoY (8:30 AM) ▪ Import Price Index (8:30 AM) ▪ Housing Starts (8:30 AM) ▪ Unemployment Rate (8:30 AM) ▪ Industrial Production YoY (9:15 AM) ▪ Atlanta Fed GDPNow (1:00 PM) ▪ TIC Net Long-Term Transactions (4:00 PM) 📈 Earnings ▪ Pre-Market: $UNTY ▪ After Hours: $WALD 📺 Stocktwits Shows ▪ Daily Rip Live with @MichaelNaussCMT and @tradingmindsetanddata (9am) ▪ The Weekend Rip (4:30pm) *Times in EDT
2 · Reply
Latest News on WALD
Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting

Nov 16, 2025, 1:02 AM EST - 19 hours ago

Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting

Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities

Nov 14, 2025, 5:05 PM EST - 2 days ago

Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities

Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates

Nov 12, 2025, 7:33 AM EST - 4 days ago

Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates

Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum

Oct 8, 2025, 8:00 AM EDT - 5 weeks ago

Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum

Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand

Sep 10, 2025, 6:45 AM EDT - 2 months ago

Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand

Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation

Aug 18, 2025, 5:43 PM EDT - 3 months ago

Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation

Waldencast Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Aug 18, 2025, 1:16 AM EDT - 3 months ago

Waldencast Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand

Jul 23, 2025, 6:45 AM EDT - 4 months ago

Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand

Waldencast: Learning To Grow Hurts Sometimes

Jun 6, 2025, 12:07 PM EDT - 5 months ago

Waldencast: Learning To Grow Hurts Sometimes

Waldencast plc (WALD) Q1 2025 Earnings Call Transcript

May 14, 2025, 12:49 PM EDT - 6 months ago

Waldencast plc (WALD) Q1 2025 Earnings Call Transcript

Waldencast Reports Q1 2025 Financial Results

May 13, 2025, 4:15 PM EDT - 6 months ago

Waldencast Reports Q1 2025 Financial Results

Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast

May 6, 2025, 4:05 PM EDT - 6 months ago

Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast

Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream

Apr 22, 2025, 8:30 AM EDT - 7 months ago

Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream

Waldencast plc (WALD) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 2:59 PM EDT - 8 months ago

Waldencast plc (WALD) Q4 2024 Earnings Call Transcript

Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results

Mar 18, 2025, 4:15 PM EDT - 8 months ago

Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results

Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast

Mar 11, 2025, 4:05 PM EDT - 8 months ago

Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast

Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection

Feb 10, 2025, 9:00 AM EST - 9 months ago

Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection

Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates

Jan 30, 2025, 4:05 PM EST - 10 months ago

Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates

Waldencast Announces Participation in the 2025 IMCAS World Congress

Jan 29, 2025, 7:00 AM EST - 10 months ago

Waldencast Announces Participation in the 2025 IMCAS World Congress

Milk Makeup to Launch at Ulta Beauty This Spring

Jan 28, 2025, 6:45 AM EST - 10 months ago

Milk Makeup to Launch at Ulta Beauty This Spring

Waldencast Announces Participation in the ICR Conference 2025

Jan 6, 2025, 4:05 PM EST - 11 months ago

Waldencast Announces Participation in the ICR Conference 2025

Waldencast plc. (WALD) Q3 2024 Earnings Call Transcript

Nov 22, 2024, 7:20 PM EST - 1 year ago

Waldencast plc. (WALD) Q3 2024 Earnings Call Transcript

Waldencast Reports Q3 2024 Financial Results

Nov 20, 2024, 5:00 PM EST - 1 year ago

Waldencast Reports Q3 2024 Financial Results

Waldencast plc Announces Third Quarter Fiscal 2024 Results Conference Call and Webcast

Nov 13, 2024, 4:05 PM EST - 1 year ago

Waldencast plc Announces Third Quarter Fiscal 2024 Results Conference Call and Webcast

Waldencast plc Announces Board Appointments and Annual General Meeting

Oct 7, 2024, 5:10 PM EDT - 1 year ago

Waldencast plc Announces Board Appointments and Annual General Meeting

Obagi Medical Announces the Launch of ELASTIDERM® Lift Up & Sculpt Facial Moisturizer and ELASTIDERM® Advanced Filler Concentrate

Sep 9, 2024, 9:37 AM EDT - 1 year ago

Obagi Medical Announces the Launch of ELASTIDERM® Lift Up & Sculpt Facial Moisturizer and ELASTIDERM® Advanced Filler Concentrate

Waldencast plc (WALD) Q2 2024 Earnings Call Transcript

Aug 28, 2024, 2:30 PM EDT - 1 year ago

Waldencast plc (WALD) Q2 2024 Earnings Call Transcript

Waldencast Reports Q2 2024 Financial Results

Aug 27, 2024, 5:26 PM EDT - 1 year ago

Waldencast Reports Q2 2024 Financial Results

Waldencast plc Provides Second Quarter and First Half Fiscal 2024 Earnings Conference Call and Webcast Information

Aug 21, 2024, 6:45 AM EDT - 1 year ago

Waldencast plc Provides Second Quarter and First Half Fiscal 2024 Earnings Conference Call and Webcast Information

Waldencast Announces Participation in the Canaccord Genuity 44th Annual Growth Conference

Aug 7, 2024, 4:15 PM EDT - 1 year ago

Waldencast Announces Participation in the Canaccord Genuity 44th Annual Growth Conference

Waldencast Announces Participation in Upcoming Investor Conferences

May 30, 2024, 6:45 AM EDT - 1 year ago

Waldencast Announces Participation in Upcoming Investor Conferences

Waldencast plc (WALD) Q1 2024 Earnings Call Transcript

May 22, 2024, 7:33 AM EDT - 1 year ago

Waldencast plc (WALD) Q1 2024 Earnings Call Transcript

Waldencast Reports Q1 2024 Financial Results

May 21, 2024, 6:45 AM EDT - 1 year ago

Waldencast Reports Q1 2024 Financial Results

Waldencast plc Announces First Quarter Fiscal 2024 Earnings Release Date, Conference Call and Webcast

May 13, 2024, 4:15 PM EDT - 1 year ago

Waldencast plc Announces First Quarter Fiscal 2024 Earnings Release Date, Conference Call and Webcast

Waldencast Announces Participation in CreatorIQ Connect Europe

May 1, 2024, 4:05 PM EDT - 1 year ago

Waldencast Announces Participation in CreatorIQ Connect Europe

Waldencast Reports Fiscal Year 2023 Financial Results

Apr 30, 2024, 6:45 AM EDT - 1 year ago

Waldencast Reports Fiscal Year 2023 Financial Results

Waldencast Regains Compliance with Nasdaq Filing Requirements

Mar 25, 2024, 5:05 PM EDT - 1 year ago

Waldencast Regains Compliance with Nasdaq Filing Requirements

Johnson Fistel, LLP is Investigating Waldencast for Violation of Securities Laws; WALD, WALDW

Mar 21, 2024, 9:26 AM EDT - 1 year ago

Johnson Fistel, LLP is Investigating Waldencast for Violation of Securities Laws; WALD, WALDW

Waldencast Reports First Half 2023 Results

Mar 20, 2024, 10:00 PM EDT - 1 year ago

Waldencast Reports First Half 2023 Results

Obagi Cosmeceuticals Announces the Launch of Daily Hydro-Drops® Rejuvenating Eye Gel Cream

Mar 7, 2024, 9:00 AM EST - 1 year ago

Obagi Cosmeceuticals Announces the Launch of Daily Hydro-Drops® Rejuvenating Eye Gel Cream

Waldencast Receives Positive Nasdaq Listing Determination

Feb 26, 2024, 6:55 AM EST - 1 year ago

Waldencast Receives Positive Nasdaq Listing Determination

Waldencast plc (WALD, WALDW) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Feb 26, 2024, 4:00 AM EST - 1 year ago

Waldencast plc (WALD, WALDW) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Waldencast Announces New “Creative Council” of Industry Pioneers and Disruptors

Feb 22, 2024, 9:15 AM EST - 1 year ago

Waldencast Announces New “Creative Council” of Industry Pioneers and Disruptors

Dr. Suzan Obagi Appointed as Chief Medical Director at Obagi Cosmeceuticals, a Subsidiary of Waldencast plc.

Feb 20, 2024, 9:00 AM EST - 1 year ago

Dr. Suzan Obagi Appointed as Chief Medical Director at Obagi Cosmeceuticals, a Subsidiary of Waldencast plc.

Waldencast Announces Participation in the TD Cowen Glowing Ahead: Beauty & Wellness Summit

Feb 7, 2024, 6:45 AM EST - 1 year ago

Waldencast Announces Participation in the TD Cowen Glowing Ahead: Beauty & Wellness Summit

Waldencast Names Manuel Manfredi as Chief Financial Officer

Jan 31, 2024, 5:10 PM EST - 1 year ago

Waldencast Names Manuel Manfredi as Chief Financial Officer

AlertsAndNews
AlertsAndNews Nov. 16 at 11:25 PM
$WALD Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting "Interim data from the ongoing study of Obagi Nu-Cil® BioStim™ Scalp Serum highlights improvements in scalp health and hair appearance at three months."
0 · Reply
premarketmaker
premarketmaker Nov. 14 at 10:51 PM
$WALD
0 · Reply
DARKP00L
DARKP00L Nov. 14 at 10:39 PM
$WALD 17:09 on Nov. 14 2025 Waldencast Plc Sells Its Rights To The "Obagi" Trademark In Japan To Rohto Pharmaceutical For $82.5M #tradeideas
0 · Reply
premarketmaker
premarketmaker Nov. 14 at 10:38 PM
$WALD big sale just announced!
0 · Reply
premarketmaker
premarketmaker Nov. 14 at 10:18 PM
$WALD $2.62 upper targets product scope
0 · Reply
MahiMe
MahiMe Nov. 14 at 10:10 PM
$WALD Waldencast (NASDAQ: WALD) announced a $82.5 million sale of its rights to the “Obagi” trademark in Japan to Rohto Pharmaceutical and a new $225 million secured, three-year first-lien term loan facility with funds managed by Lumina Capital, with proceeds expected by Nov 17, 2025.
0 · Reply
MahiMe
MahiMe Nov. 14 at 10:08 PM
$WALD $WALD Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities https://www.stocktitan.net/news/WALD/waldencast-plc-strengthens-balance-sheet-position-with-the-twbx7vmb0t8u.html
0 · Reply
Zero11
Zero11 Nov. 11 at 10:02 PM
$WALD arent the esrnings supposed to come out today
0 · Reply
SmartMoneySarge
SmartMoneySarge Oct. 17 at 4:17 AM
$UNTY $WALD
0 · Reply
Stocktwits
Stocktwits Oct. 16 at 8:21 PM
🚨 What's Happening Tomorrow ▪ Hourly Earnings YoY (8:30 AM) ▪ Import Price Index (8:30 AM) ▪ Housing Starts (8:30 AM) ▪ Unemployment Rate (8:30 AM) ▪ Industrial Production YoY (9:15 AM) ▪ Atlanta Fed GDPNow (1:00 PM) ▪ TIC Net Long-Term Transactions (4:00 PM) 📈 Earnings ▪ Pre-Market: $UNTY ▪ After Hours: $WALD 📺 Stocktwits Shows ▪ Daily Rip Live with @MichaelNaussCMT and @tradingmindsetanddata (9am) ▪ The Weekend Rip (4:30pm) *Times in EDT
2 · Reply
Stocktwits
Stocktwits Oct. 9 at 8:54 PM
🚨 What's Happening Tomorrow ▪ Nonfarm Payrolls (8:30 AM) ▪ Private Nonfarm Payrolls (8:30 AM) ▪ U6 Unemployment Rate (8:30 AM) ▪ Unemployment Rate (8:30 AM) ▪ Michigan Consumer Expectations (10:00 AM) ▪ Federal Budget Balance (2:00 PM) 📈 Earnings ▪ Pre-Market: $UNTY ▪ After Hours: $WALD 📺 Stocktwits Shows ▪ Daily Rip Live with @MichaelNaussCMT and @tradingmindsetanddata (9am) ▪ The Weekend Rip (4:30pm) *Times in EDT
4 · Reply
Bullish_Trader555
Bullish_Trader555 Oct. 8 at 12:08 PM
$WALD Obagi Medical launches Nu-Cil BioStim Scalp Serum (WALD)
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 3 at 9:37 AM
$WALD Great piece that accurately captures WALD's current position. So if you want to refresh your understanding of WALD or learn about WALD for the first time, this is essential reading. https://beyondspx.com/quote/WALD/analysis/waldencast-a-beauty-platform-s-strategic-evolution-and-aesthetic-expansion-nasdaq-wald
0 · Reply
As753
As753 Oct. 2 at 8:27 PM
$WALD still the target.
0 · Reply
Winning_calls
Winning_calls Sep. 29 at 3:05 AM
$WALD pick me up @ $2.04
0 · Reply
As753
As753 Sep. 18 at 8:11 PM
$WALD soon
0 · Reply
As753
As753 Sep. 10 at 11:57 AM
$WALD https://www.rttnews.com/3573063/waldencast-says-obagi-saypha-magiq-injectable-hyaluronic-acid-gel-approved-in-u-s.aspx
0 · Reply
As753
As753 Sep. 10 at 11:00 AM
$WALD 3+
0 · Reply
MEC1069
MEC1069 Sep. 10 at 10:57 AM
$WALD https://www.moomoo.com/news/flash/21033264/waldencast-announces-fda-approval-of-obagi-saypha-magiq-injectable-hyaluronic
0 · Reply
As753
As753 Sep. 9 at 6:14 PM
$WALD lets go 🔥🔥
0 · Reply
As753
As753 Sep. 8 at 4:08 PM
$WALD soon
0 · Reply
KimberleyAnn
KimberleyAnn Sep. 8 at 12:36 PM
$WALD
0 · Reply